Sign In
Vical, Incorporated (VICL)
SHARE
Email Confirmation
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME
Overview
News
People
Financials
Company Information
Vijay B. Samant, CEO/President/Director
10390 Pacific Center Court
San Diego, CA 92121-4340
US
Map it 
Overview
The Company is engaged in the research and development of biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.
Press Releases
-
Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans Dec-11-2008, 06:30AM EST
-
SARS Vaccine Achieves Neutralizing Responses in First U.S. Human Trial Dec-09-2008, 06:30AM EST
-
Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey Dec-03-2008, 06:30AM EST
-
Vical Announces Strategic Restructuring and Staff Reduction Nov-21-2008, 06:30AM EST
Employees
Number of Employees: 154
Revenue per Employee: $41,116
Financials
Quarterly
Annual
| Income Statement | 09/2008 | 06/2008 | 03/2008 | 12/2007 |
|---|---|---|---|---|
| Sales | 2.25 Mil. | 2.36 Mil. | -11.8 Mil. | 2.08 Mil. |
| Gross Operating Profit | 301 K. | -425 K. | 12.57 Mil. | -1.71 Mil. |
| Operating Income before D & A (EBITDA) | -8.18 Mil. | -9.35 Mil. | -9.07 Mil. | -9.48 Mil. |
| Total Income Before Interest Expenses (EBIT) | -8.48 Mil. | -9.56 Mil. | -8.85 Mil. | -9.22 Mil. |
| Total Net Income | -8.48 Mil. | -9.56 Mil. | -8.86 Mil. | -9.24 Mil. |
| Basic EPS, Total | -0.21 | -0.24 | -0.23 | -0.24 |
| Diluted EPS, Total | -0.21 | -0.24 | -0.23 | -0.24 |
| BALANCE STATEMENT | 09/2008 | 06/2008 | 03/2008 | 12/2007 |
|---|---|---|---|---|
| Cash and Equivalents | 37.96 Mil. | 38.53 Mil. | 35.35 Mil. | 38.83 Mil. |
| Total Assets | 53.59 Mil. | 53.64 Mil. | 72.75 Mil. | 78.23 Mil. |
| Total Liabilities | 7.57 Mil. | 5.97 Mil. | 8.11 Mil. | 5.77 Mil. |
| Total Capitalization | 66.41 Mil. | 70.55 Mil. | 79.91 Mil. | 88.29 Mil. |
| Cash Flow | 09/2008 | 06/2008 | 03/2008 | 12/2007 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | -16.45 Mil. | -10.34 Mil. | -24.18 Mil. | -19.39 Mil. |
| Net Cash From Investing Activities | 15.47 Mil. | 13.76 Mil. | 42.93 Mil. | 41.11 Mil. |
| Net Cash From Financing Activities | 3.58 Mil. | -242 K. | -2.76 Mil. | -2.26 Mil. |
| Net Change in Cash & Cash Equivalents | 2.61 Mil. | 3.18 Mil. | 15.98 Mil. | 19.46 Mil. |
| Income Statement | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Sales | -3.26 Mil. | -3.28 Mil. | -3.59 Mil. | -3.64 Mil. |
| Gross Operating Profit | 8.78 Mil. | 18.02 Mil. | 15.6 Mil. | 18.18 Mil. |
| Operating Income before D & A (EBITDA) | -37 Mil. | -23.13 Mil. | -22.06 Mil. | -21.51 Mil. |
| Total Income Before Interest Expenses (EBIT) | -35.8 Mil. | -22.88 Mil. | -23.82 Mil. | -22.94 Mil. |
| Total Net Income | -35.89 Mil. | -23.15 Mil. | -24.36 Mil. | -23.73 Mil. |
| Basic EPS, Total | -0.92 | -0.74 | -0.99 | -1.05 |
| Diluted EPS, Total | -0.92 | -0.74 | -0.99 | -1.05 |
| BALANCE STATEMENT | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Cash and Equivalents | 35.35 Mil. | 19.36 Mil. | 5.71 Mil. | 17.67 Mil. |
| Total Assets | 72.75 Mil. | 105.44 Mil. | 72.26 Mil. | 77.41 Mil. |
| Total Liabilities | 8.11 Mil. | 8.15 Mil. | 8.78 Mil. | 10.11 Mil. |
| Total Capitalization | 79.91 Mil. | 114.12 Mil. | 80.31 Mil. | 82.91 Mil. |
| Cash Flow | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | -24.18 Mil. | -15.67 Mil. | -22.78 Mil. | -21.07 Mil. |
| Net Cash From Investing Activities | 42.93 Mil. | -21.51 Mil. | -6.74 Mil. | 9.79 Mil. |
| Net Cash From Financing Activities | -2.76 Mil. | 50.83 Mil. | 17.56 Mil. | 12.37 Mil. |
| Net Change in Cash & Cash Equivalents | 15.98 Mil. | 13.65 Mil. | -11.96 Mil. | 1.09 Mil. |
Related Companies by Market Cap
Company Name
Price
Change
Market Cap
146.24 Mil.
149.13 Mil.
145.36 Mil.
149.87 Mil.
Company Profile Change Request
The data provided in our company profiles comes from third party information providers.- To request a change please click here
Also in Portfolio.com
Most Read
Most Emailed
Recently Commented
TOP 5
(Daily)
A smart take on the top stories shaping the business world.
Executives & Careers
(Tuesdays)
A weekly guide to the personalities and ideas that are transforming the business world.
Inside Portfolio.com
(Wednesdays)
Our roundup of the week's best from Portfolio.com.
Culture & Lifestyle
(Fridays)
A weekly guide to the best ways to spend your time - and money.
In This Issue
(Monthly)
Be the first to know when the latest issue of Condé Nast Portfolio magazine is online.
RSS Most Read
Mobile